Dr. Julia Lindsay Boland, MD

Dr. Boland practices at Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles.

Dr. Boland's NPI, 1922637891, was assigned on April 3, 2020. Dr. Boland graduated from Drexel University College Of Medicine in 2020. Dr. Boland's California license number on file is A190494.

Dr. Boland's primary practice is Olive View-UCLA Medical Center, at 14445 Olive View Drive, Sylmar, CA 91342 in Los Angeles County. The practice phone is (818) 364-1555.

Dr. Boland's primary practice is Olive View-UCLA Medical Center in Sylmar, California, part of County of Los Angeles. Dr. Boland is also affiliated with OHSU Hospital. The medical group on file is Kaiser Permanente Northwest. Dmand AI also links Dr. Boland to 1 more medical group, named with a free account. Dr. Boland's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boland practices, 2 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Boland's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Boland is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Boland's licenses on file in 3 states: California, Washington and Oregon.

CMS data shows 1,618 Medicare services from Dr. Boland across 9 procedure codes in 2024, for 406 Medicare patients. Medicare paid $127,463 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 406 Medicare patients who saw Dr. Boland in 2024. The largest group is 75 to 84, with 155 patients. 75% of them have arthritis, and 75% have high blood pressure. 39% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boland's median patient age at 64, with 46% women.

In 2024, Dr. Boland wrote 1,020 Medicare Part D claims for 171 patients. 80% of them were for generic drugs. CMS names the drug for 528 of them, across 22 drugs with 11 or more claims each, at $44,941 in total drug cost. In 2023, CMS named 71 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Boland for performance year 2024, reported through an alternative payment model (APM).

Dmand AI links 3 papers to Dr. Boland, published from 2020 to 2021.

CMS Open Payments shows 15 general payments to Dr. Boland from 11 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 63% of the total. Sanofi and Genzyme US Companies paid the most, $232.

Dr. Boland graduated from Drexel University College Of Medicine in 2020.

Dr. Boland is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.